These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections. White JS; Gee C; Ledger WJ J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395 [No Abstract] [Full Text] [Related]
25. Cefamandole and cefoxitin. Med Lett Drugs Ther; 1979 Feb; 21(3):13-5. PubMed ID: 310945 [No Abstract] [Full Text] [Related]
26. Use of cefoxitin sodium in moderate to severe surgical infections. Schumer W; Nicholas RL; Acharya A J Antimicrob Chemother; 1978 Jul; 4(B):231-3. PubMed ID: 357393 [No Abstract] [Full Text] [Related]
27. Clinical use of cefoxitin, a new semisynthetic cephamycin. Little PJ; Peddie BA N Z Med J; 1978 Jul; 88(616):46-9. PubMed ID: 279853 [TBL] [Abstract][Full Text] [Related]
28. Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria. Gurwith M; Albritton W; Lank B; Harding G; Ronald A Antimicrob Agents Chemother; 1978 Feb; 13(2):255-60. PubMed ID: 348096 [TBL] [Abstract][Full Text] [Related]
29. Surgical considerations in skin and soft-tissue infections and osteomyelitis treated with cefoxitin sodium. Perkins RL J Antimicrob Chemother; 1978 Jul; 4(B):183-7. PubMed ID: 690021 [No Abstract] [Full Text] [Related]
30. [Clinical trial of cefoxitin in children (author's transl)]. Okada T; Hirao F; Furukawa S Jpn J Antibiot; 1981 Mar; 34(3):346-51. PubMed ID: 7026820 [TBL] [Abstract][Full Text] [Related]
31. [Clinical experimentation of cefoxitin in intensive therapy]. Merlo F; Taioli G; Morini M; Cantanna R; Vaglia A Minerva Anestesiol; 1984 Apr; 50(4):157-60. PubMed ID: 6382061 [No Abstract] [Full Text] [Related]
32. Effect of probenecid on serum cefoxitin concentrations. Bint AJ; Reeves DS; Holt HA J Antimicrob Chemother; 1977 Nov; 3(6):627-8. PubMed ID: 599129 [No Abstract] [Full Text] [Related]
33. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic. McCloskey RV Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968 [TBL] [Abstract][Full Text] [Related]
35. Studies with cefuroxime and cefoxitin. Geddes AM; McGhie D; Ball AP; Gould I Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of cefotetan versus cefoxitin plus metronidazole in the treatment of gynecological infections. Schwiersch U; Lang N Chemioterapia; 1987 Jun; 6(2 Suppl):541-2. PubMed ID: 3334618 [No Abstract] [Full Text] [Related]
37. In-vitro and in-vivo comparison of mezlocillin and cefoxitin. LeFrock JL; Molavi A; Rolston K; Smith B; Schell R; Chandrasekar P; Carr B J Antimicrob Chemother; 1983 May; 11 Suppl C():83-90. PubMed ID: 6352609 [TBL] [Abstract][Full Text] [Related]
38. [Clinical experience with cefoxitin in bacterial infections of children (author's transl)]. Yuasa Y; Ichioka T; Sekiguchi T; Miyao M; Toi C; Hayashi K; Yamashita K; Tanaka H Jpn J Antibiot; 1981 Mar; 34(3):359-66. PubMed ID: 7289028 [TBL] [Abstract][Full Text] [Related]